These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 18178361

  • 21. [Prospective study of Staphylococcus aureus with reduced susceptibility to glycopeptides].
    Cantón R, Mir N, Martínez-Ferrer M, Sánchez del Saz B, Soler I, Baquero F.
    Rev Esp Quimioter; 1999 Mar; 12(1):48-53. PubMed ID: 10896469
    [Abstract] [Full Text] [Related]

  • 22. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS, Watters AA, Fritsche TR, Jones RN.
    BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104
    [Abstract] [Full Text] [Related]

  • 23. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
    Tiwari HK, Sen MR.
    BMC Infect Dis; 2006 Oct 26; 6():156. PubMed ID: 17067393
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).
    Mendes RE, Sader HS, Jones RN.
    Int J Antimicrob Agents; 2010 Oct 26; 36(4):374-9. PubMed ID: 20598860
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.
    Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC, Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group.
    Clin Infect Dis; 2003 Feb 15; 36(4):429-39. PubMed ID: 12567300
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F.
    J Antimicrob Chemother; 2006 Dec 15; 58(6):1177-84. PubMed ID: 17062609
    [Abstract] [Full Text] [Related]

  • 29. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
    Kotlus BS, Wymbs RA, Vellozzi EM, Udell IJ.
    Am J Ophthalmol; 2006 Nov 15; 142(5):726-9. PubMed ID: 17056356
    [Abstract] [Full Text] [Related]

  • 30. Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital.
    Hsueh PR, Lee SY, Perng CL, Chang TY, Lu JJ.
    Int J Antimicrob Agents; 2010 Oct 15; 36(4):307-12. PubMed ID: 20685086
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Leonard SN, Rybak MJ.
    J Antimicrob Chemother; 2009 Jan 15; 63(1):155-60. PubMed ID: 18984644
    [Abstract] [Full Text] [Related]

  • 32. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
    Torrico M, Aguilar L, Sevillano D, Giménez MJ, Alou L, González N, Cafini F, Cleeland R, Prieto J.
    Int J Antimicrob Agents; 2011 Apr 15; 37(4):332-8. PubMed ID: 21388792
    [Abstract] [Full Text] [Related]

  • 33. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA).
    Howden BP.
    Intern Med J; 2005 Dec 15; 35 Suppl 2():S136-40. PubMed ID: 16271057
    [Abstract] [Full Text] [Related]

  • 34. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model.
    Zhanel GG, Rossnagel E, Nichol K, Cox L, Karlowsky JA, Zelenitsky S, Noreddin AM, Hoban DJ.
    J Antimicrob Chemother; 2011 Jun 15; 66(6):1301-5. PubMed ID: 21429940
    [Abstract] [Full Text] [Related]

  • 35. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
    Alós JI, García-Cañas A, García-Hierro P, Rodríguez-Salvanés F.
    J Antimicrob Chemother; 2008 Oct 15; 62(4):773-5. PubMed ID: 18552338
    [Abstract] [Full Text] [Related]

  • 36. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran.
    Aligholi M, Emaneini M, Jabalameli F, Shahsavan S, Dabiri H, Sedaght H.
    Med Princ Pract; 2008 Oct 15; 17(5):432-4. PubMed ID: 18685289
    [Abstract] [Full Text] [Related]

  • 37. [Detection methods for drug-resistant bacteria in routine examination--VISA].
    Kinoshita S, Nakamachi Y.
    Rinsho Byori; 2000 Jan 15; Suppl 111():69-74. PubMed ID: 10804795
    [Abstract] [Full Text] [Related]

  • 38. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Garrison MW, Nuemiller JJ.
    Int J Antimicrob Agents; 2007 Feb 15; 29(2):191-6. PubMed ID: 17174074
    [Abstract] [Full Text] [Related]

  • 39. Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2000 Jan 07; 48(51-52):1165-7. PubMed ID: 11266244
    [Abstract] [Full Text] [Related]

  • 40. MRSA--the tip of the iceberg.
    Appelbaum PC.
    Clin Microbiol Infect; 2006 Apr 07; 12 Suppl 2():3-10. PubMed ID: 16524422
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.